DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



The levonorgestrel-releasing intrauterine device reduces CA-125 serum levels in patients with endometriosis.

Author(s): de Sa Rosa e Silva AC, Rosa e Silva JC, Nogueira AA, Petta CA, Abrao MS, Ferriani RA

Affiliation(s): Department of Obstetrics and Gynecology, School of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Brazil. anasars@convex.com.br

Publication date & source: 2006-09, Fertil Steril., 86(3):742-4. Epub 2006 Jun 19.

Publication type: Randomized Controlled Trial

This study compared the long-term effects of the levonorgestrel-releasing intrauterine device with those of GnRH agonist administration on serum levels of CA-125 in patients with endometriosis. The levonorgestrel-releasing intrauterine device was found to be as efficient as GnRH agonist in reducing CA-125 serum levels.

Page last updated: 2006-11-04

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017